Mr. Ryan Roebuck reports

APOLO V ACQUISITION CORP. ANNOUNCES FILING OF FILING STATEMENT IN CONNECTION WITH QUALIFYING TRANSACTION

Apolo V Acquisition Corp. has filed its filing statement dated March 24, 2026, on its SEDAR+ profile in connection with the proposed business combination among Apolo V, TelyRx Inc., TelyRx Finco Inc., 1001474388 Ontario Inc. and Apolo V MergerCo Inc. In conjunction with, and on or about March 26, 2026, Finco is anticipated to complete a best effort private placement of a minimum of 6,091,111 subscription receipts of Finco and a maximum of 9,136,666 subscription receipts at a subscription price of $4.50 per subscription receipt for minimum aggregate gross proceeds of $20-million (U.S.) (or $27.41-million (Canadian)) and maximum aggregate proceeds of $30-million (U.S.) (or $$41,115,000 (Canadian)). The proposed transaction, once complete, is expected to result in the reverse takeover of Apolo V (following completion of the proposed transaction, the resulting issuer) and will constitute Apolo V's qualifying transaction, as such term is defined in the policies of the TSX Venture Exchange. It is anticipated that the proposed transaction will close on or about March 31, 2026.

The TSX-V has conditionally approved the proposed transaction, and the Toronto Stock Exchange has conditionally approved the listing of the subordinate voting shares of the resulting issuer on the Toronto Stock Exchange under ticker symbol TELY following completion of the proposed transaction. Final approval from both the TSX-V and TSX is subject to TelyRx and the resulting issuer meeting certain customary conditions required by the TSX-V and TSX, as applicable. Apolo V will issue a press release once the TSX confirms the date when trading of the shares is expected to commence on the TSX.

Investors are encouraged to review the filing statement on Apolo V's SEDAR+ profile, as well as the news releases of Apolo V dated Dec. 5, 2025, Jan. 21, 2026, Feb. 20, 2026, and March 6, 2026. The filing statement provides detailed information about, among other things, the proposed transaction, Apolo V, TelyRx and the resulting issuer. Investors are cautioned that, except as disclosed in the filing statement, any information released or received with respect to the proposed transaction may not be accurate or complete and should not be relied upon.

About Apolo V Acquisition Corp.

Apolo V was incorporated under the Business Corporations Act (Ontario) on April 2, 2025, and is a capital pool company listed on the TSX-V. Apolo V has no commercial operations and has no assets other than cash. Apolo V's only business is to identify and evaluate assets or businesses with a view to completing a qualifying transaction.

Trading in the securities of a capital pool company should be considered highly speculative. The common shares of Apolo V are currently halted from trading on the TSX-V, and trading is not expected to resume until closing of the proposed transaction.

We seek Safe Harbor.